ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Adult Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

24,019Medicare Part D Prescriptions Filled, Including Refills

Rank: 5 out of 129

$647K Total Retail Price of All Prescriptions

Rank: 14 out of 129

572 Patients Receiving at Least One Drug in Part D
81%Patients 65 Years and Older
83% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

2% of this provider’s 20,580 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$27 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

42 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
SIMVASTATIN 1,263 1,058 1 1
OMEPRAZOLE 1,230 1,025 2 2
LISINOPRIL 1,175 949 3 3
METFORMIN HCL 1,034 850 4 6
ALENDRONATE SODIUM 858 803 5 13
HYDROCHLOROTHIAZIDE 777 638 6 9
VITAMIN D2 743 653 7 74
TEMAZEPAM 578 551 8 31
ENALAPRIL MALEATE 568 452 9 34
AMLODIPINE BESYLATE 532 452 10 4
LEVOTHYROXINE SODIUM 485 453 11 5
METOPROLOL TARTRATE 479 440 12 7
LOVASTATIN 447 390 13 11
VIAGRA 435 381 14 52
IBUPROFEN 394 328 15 30
CARVEDILOL 368 327 16 18
ATACAND 360 341 10 17 167
FUROSEMIDE 349 326 18 8
ZOLPIDEM TARTRATE 306 263 19 14
CLOPIDOGREL 291 230 20 23
ATENOLOL 225 193 21 10
LACTULOSE 221 192 22 71
CLONAZEPAM 218 195 23 97
RANITIDINE HCL 216 195 24 25
TAMSULOSIN HCL 216 207 24 37
LISINOPRIL-HYDROCHLOROTHIAZIDE 211 175 26 32
ALPRAZOLAM 203 155 27 28
NAPROXEN 198 161 28 62
CLOTRIMAZOLE-BETAMETHASONE 189 146 29 66
PROAIR HFA 187 136 30 53
MICARDIS 170 159 31 203
ATACAND HCT 166 162 10 32 233
DILTIAZEM ER 166 154 32 144
INSULIN SYRINGE 161 96 34 70
FAMOTIDINE 155 142 35 60
CIALIS 153 114 36 136
METOPROLOL SUCCINATE 152 125 37 17
PLAVIX 150 129 38 36
GABAPENTIN 149 101 39 16
FENOFIBRATE 144 144 40 45
GLYBURIDE-METFORMIN HCL 140 114 R 41 78
DIGOXIN 139 127 42 47
GLIPIZIDE 138 101 43 38
TRAMADOL HCL 135 120 44 24
DOXAZOSIN MESYLATE 134 116 45 58
ALLOPURINOL 123 108 46 42
ISOSORBIDE MONONITRATE ER 120 108 47 57
ESCITALOPRAM OXALATE 118 104 48 68
CHLORTHALIDONE 117 95 49 181
GLYBURIDE 114 96 R 50 55
WARFARIN SODIUM 113 91 51 21
NAMENDA 111 111 52 48
METFORMIN HCL ER 110 101 53 118
CLONIDINE HCL 109 106 54 49
AMLODIPINE BESYLATE-BENAZEPRIL 107 106 55 64
SYMBICORT 99 94 56 170
PENTOXIFYLLINE 97 89 57 151
LORAZEPAM 97 87 57 79
MECLIZINE HCL 96 90 59 75
SULFAMETHOXAZOLE-TRIMETHOPRIM 95 88 60 138
FINASTERIDE 90 79 61 84
LANSOPRAZOLE 89 89 62 111
LANTUS 87 77 63 59
DICLOFENAC SODIUM 86 80 64 65
NIFEDICAL XL 83 82 65 233
KLOR-CON 10 81 80 66 122
ACTOS 81 68 66 103
FELODIPINE ER 80 80 68 230
ADVAIR DISKUS 79 47 69 46
LOSARTAN POTASSIUM 75 63 70 12
PAROXETINE HCL 74 61 71 56
PROCTOSOL-HC 71 68 72 292
CILOSTAZOL 71 71 72 137
GLIPIZIDE ER 71 68 72 141
SERTRALINE HCL 70 53 75 39
NOVOLIN 70-30 69 31 76 108
HYDRALAZINE HCL 69 59 76 110
PRAVASTATIN SODIUM 66 46 78 19
AVODART 65 65 79 152
LUMIGAN 63 63 80 242
SPIRONOLACTONE 62 44 81 80
VOLTAREN 62 58 81 68
METOCLOPRAMIDE HCL 60 47 83 104
FOLIC ACID 60 51 83 72
AMITRIPTYLINE HCL 59 55 R 85 130
TRICOR 58 58 86 140
AMMONIUM LACTATE 57 52 87 108
TRAMADOL HCL-ACETAMINOPHEN 56 53 88 142
CIPROFLOXACIN HCL 55 51 89 62
MEGESTROL ACETATE 53 50 R 90 86
CICLOPIROX 52 52 91 178
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 28, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.